PEPFAR had been set to lead the rollout of Gilead Science's lenacapavir, which has been hailed as a "miracle" of HIV ...

God saved Trump, prayer meetings before press conferences, and a certainty that THE LORD is on their side are just a few of the ideas keeping the notoriously dishonest Karoline Leavitt fighting ...

Life sciences companies have decided to chop hundreds of Bay Area jobs in a fresh wave of layoffs that hint at ongoing ...

When Wall Street analysts decide to come out of their caves and boost a certain stock, retail investors should pay attention ...

As we count down the days until the final season of The Handmaid’s Tale, the Eyes On Gilead team is here with an essential ...

News of potential federal budget cuts impacting HIV drugs in the U.S. was quickly reflected in a dip in share prices for top ...

On the same day the Trump Administration unceremoniously shut down the U.S. Department of Health and Human Services Regional Office in San Francisco, a major HIV drug maker ...

Gilead CEO Daniel O’Day saw another rise in his pay in 2024, reflecting the steadily upward trajectory of the company since ...

Welcome back to Gilead. “The Handmaid’s Tale” sequel series “The Testaments” has officially received a series order from Hulu ...

Gilead Sciences Inc. CEO Daniel O'Day's compensation rose 4.8% last year to $23.7 million — roughly $97 for every buck made ...

The Testaments also rounds out its cast with 9 new actors: Mabel Li, Amy Seimetz, Brad Alexander, Zarrin Darnell-Martin, Eva ...

"The Handmaid's Tale" is officially getting a sequel series: "The Testaments," starring Ann Dowd and executive produced by ...